121669-69-0

Basic information

• Product Name: 4-Methyl-1H-pyrazole-1-carboxylic acid 1,1-dimethylethyl ester
• Synonyms: 1-tert-Butoxycarbonyl-4-methylpyrazole;4-Methyl-1H-pyrazole-1-carboxylic acid 1,1-dimethylethyl ester;4-Methylpyrazole-1-carboxylic acid tert-butyl ester;tert-butyl 4-methyl-1H-pyrazole-1-carboxylate;tert-butyl 4-methyl-1H-pyrazole-1-carboxylate(WXC04541)
• CAS NO: 121669-69-0
• Molecular Formula: C9H14N2O2
• Molecular Weight: 182.21966
• Mol File: 121669-69-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 255℃
• Flash Point: 108℃
• Appearance: /
• Density: 1.07
• CAS DataBase Reference: 4-Methyl-1H-pyrazole-1-carboxylic acid 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-1H-pyrazole-1-carboxylic acid 1,1-dimethylethyl ester(121669-69-0)
• EPA Substance Registry System: 4-Methyl-1H-pyrazole-1-carboxylic acid 1,1-dimethylethyl ester(121669-69-0)

Safety Data

• Hazardous Substances Data: 121669-69-0(Hazardous Substances Data)

Upstream product

• 7554-65-6 4-methyl-1H-pyrazole 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 530144-72-0 tert-butyl 4-(bromomethyl)-1H-pyrazole-1-carboxylate 

Relevant articles and documents

SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5

Disclosed are compounds having structural formula I, and related salts and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases and conditions such as kidney disease, kidney failure, kidney stones, or polycystic kidney disease, using the compounds of formula (I), and related salts and pharmaceutical compositions.

PROBES FOR IMAGING HUNTINGTIN PROTEIN

Provided are imaging agents comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and methods of their use.

CARBACEPHEM BETA-LACTAM ANTIBIOTICS

Carbacephem β-lactam antibiotics having structure (I) are disclosed, including stereoisomers, pharmaceutically acceptable salts, esters and prodrugs thereof, wherein Ar2, X, R1 and R2 are as defined herein. The compounds are useful for the treatment of bacterial infections, in particular those caused by methicillin-resistant Staphylococcus spp.